Vlado Perkovic's Publications

• Renoprotection with semaglutide and liraglutide: Direct or indirect effects?

  Conference Papers

  2020

  DIABETOLOGIA

• The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial

  Conference Abstracts

  2020

  DIABETOLOGIA

• Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

  Conference Abstracts

  2020

  DIABETOLOGIA

• Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes

  Journal articles

  2020

  Kidney International

• Effects of canagliflozin on cardiovascular death and hospitalization for heart failure by baseline estimated glomerular filtration rate: integrated analyses from the CANVAS Program and CREDENCE

  Conference Abstracts

  2020

  EUROPEAN HEART JOURNAL

• Independent predictors of heart failure in patients with type 2 diabetes and chronic kidney disease: modeling from the CREDENCE trial

  Conference Abstracts

  2020

  EUROPEAN HEART JOURNAL

• Comparative efficacy and safety of bp-lowering pharmacotherapy in patients undergoing maintenance dialysis: A network meta-analysis of randomized, controlled trials

  Journal articles

  2020

  Clinical Journal of the American Society of Nephrology

• Effects of linagliptin on cardiovascular and kidney outcomes in people with normal and reduced kidney function: Secondary analysis of the carmelina randomized trial

  Journal articles

  2020

  Diabetes Care

• Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop

  Conference Papers

  2020

  American Journal of Kidney Diseases

• Effects of allopurinol on the progression of chronic kidney disease

  Journal articles

  2020

  New England Journal of Medicine

• Biomarkers of Tubular Injury and Effects of Canagliflozin in the CANVAS Trial

  Conference Abstracts

  2020

  DIABETES

• Association between the Inflammatory Marker GDF-15 and Kidney Disease Progression: Results from the CANVAS Trial

  Conference Abstracts

  2020

  DIABETES

• The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS

  Conference Posters

  2020

• Acute Declines in EGFR during Treatment with Canagliflozin and Its Implications for Clinical Practice: Insights from CREDENCE

  Conference Presentations

  2020

• 1130-P: Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)

  Conference Posters

  2020

• EFFECTS OF SEMAGLUTIDE ON CHRONIC KIDNEY DISEASE OUTCOMES: A POST HOC POOLED ANALYSIS FROM THE SUSTAIN 6 AND PIONEER 6 TRIALS

  Conference Papers

  2020

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE VS PLACEBO: A POST HOC POOLED ANALYSIS OF SUSTAIN 6 AND PIONEER 6

  Conference Papers

  2020

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM

  Conference Abstracts

  2020

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

  Conference Abstracts

  2020

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

  Conference Abstracts

  2020

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• MO051EFFECTS OF SEMAGLUTIDE ON CHRONIC KIDNEY DISEASE OUTCOMES: A POST HOC POOLED ANALYSIS FROM THE SUSTAIN 6 AND PIONEER 6 TRIALS

  Journal articles

  2020

  Nephrology Dialysis Transplantation

• TO002REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE VS PLACEBO: A POST HOC POOLED ANALYSIS OF SUSTAIN 6 AND PIONEER 6

  Journal articles

  2020

  Nephrology Dialysis Transplantation

• 27-OR: Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease

  Journal articles

  2020

  Diabetes

• P1028EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM

  Journal articles

  2020

  Nephrology Dialysis Transplantation

• P1019CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

  Journal articles

  2020

  Nephrology Dialysis Transplantation

• P1013CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

  Journal articles

  2020

  Nephrology Dialysis Transplantation